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INTRODUCTION 
Atrial septal defect (ASD) accounts for one third of congenital 
heart disease in adults. 90% of the ASDs are fossa ovalis defect. 
Natural History is death by fourth or fifth decade when not repaired 
and when repaired at an earlier stage the survival approaches the rate 
for that of the normal population. Surgical closure of the ASD has a 
low morbidity and mortality. Surgical closure is usually accomplished 
by two methods, direct suture closure and pericardial patch closure. 
Cardiac surgeons preference to choose either of these two techniques 
to close the ASDs are very much variable. Small to moderate sized 
ASD were closed using direct suture technique and large ASDs were 
closed using pericardial patch technique.  
In the present study, we tried to identify those characteristics of the 
ASD and the surgical outcomes when either of these two techniques 
were involved. It is a retrospective study of two groups of patients, the 
direct closure group and pericardial patch closure group. 
 A comparison is made between these two groups in terms of – 
1) The mortality and morbidity associated with each group 
2) Associated anomalies in both the groups 
3) The amount of blood transfusion needed between the groups 
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4) To compare the effectiveness of symptom relief  between each 
group 
5) To compare the effect of these repairs on associated conditions 
like mitral regurgitation (MR), mitral valve prolapse (MVP) and 
tricuspid regurgitation (TR) 
6) To compare the effects of these techniques on right ventricle, 
left ventricle and mitral valve geometry  
7) To compare the cardiopulmonary bypass time, aortic cross 
clamp time and duration of surgery 
8) To compare the differences in the duration of  mechanical 
ventilation time and duration of  hospital stay 
9) To evaluate the postoperative complications like residual shunt 
and thromboembolism between the two groups 
 
   Atrial septal defect ostium secundum (ASD OS) accounts for 
5- 10% of all congenital heart disease. The gold standard for ASD is 
surgical closure of the ASD. The surgeon has the advantage of closing 
the ASD invariable of its location, size and proximity to vital 
structures. The criterion standard in the treatment of atrial septal 
defect (ASD) is direct closure of the defect by using an open approach 
with extracorporeal support. 
9
John Gibbon performed the first 
successful ASD closure by applying this method in 1953. Surgical 
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techniques and equipment have since improved to the point that the 
mortality rate from this repair approaches zero. 
 
In the usual procedure, a median sternotomy incision is 
made, and the sternum is split in the midline. Direct arterial and 
double venous (superior vena cava and inferior vena cava) 
cannulation are performed. By applying cardiopulmonary 
bypass, the aorta is clamped, and the heart is arrested with a 
cardioplegia solution. The caval snares are tightened, and the 
right atrium is opened. Most secundum defects can be closed by 
using a direct continuous suture of 3-0 or 4-0 polypropylene 
(Prolene). 
 
Caution must be taken when large defects are directly 
closed because this closure can distort the atrium. Large defects 
that rise superiorly can distort the aortic annulus if closed 
directly. These ASDs are best closed by using autologous 
pericardium or synthetic patches made of polyester polymer 
(Dacron) or polytetrafluoroethylene (PTFE). Care must be taken 
to completely remove any air or debris from the left atrium and 
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ventricle before cardiopulmonary bypass is discontinued. 
Temporary pacing wires are left in place on the right ventricle 
before the chest is closed over the drains. 
 
In this present study, comparison between the outcomes 
of direct suture and pericardial patch closure of ASD were 
analysed. The Comparison of outcomes of both the surgical 
techniques- duration of the surgery, cardio pulmonary by pass 
time, changes in chamber geometry, aortic cross clamp time, 
need for blood products, thromboembolism, infections, other 
complications, duration of hospital stay and relief from 
symptoms will be studied.  
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AIM AND OBJECTIVES  
AIM 
  To compare the outcomes following direct suture and 
pericardial patch closure in Atrial septal defect 
 
OBJECTIVE OF THE STUDY 
 
 To compare the mortality and morbidity  
 To identify associated  anomalies in both groups 
 To compare the effect of these techniques in those patients 
with Mitral valve prolapse (MVP) and Mitral regurgitation 
(MR) and Tricuspid regurgitation (TR) 
 To compare the effects of these techniques in right ventricle 
and left ventricle chamber geometry 
 To compare the complications (Residual shunt and 
Thromboembolism) 
 To compare the effectiveness of the symptom relief  
 To compare the duration of cardio pulmonary bypass time 
and surgery between the two groups 
 To compare the differences in duration of  ventilator time 
and Hospital stay 
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 To compare the amount of blood transfusion needed in the 
two groups 
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REVIEW OF LITERATURE 
An ASD is a hole of variable size in the atrial septum. 
Recognition of ASD has been possible only in the last 60 years. By 
1941, Bedford and colleagues had started to diagnose ASDs clinically. 
With the introduction of catheterization studies in 1950s a correct 
diagnosis was possible. With the invention of echocardiogram, one 
could easily visualize an ASD by the bedside without causing much 
difficulty for the patient. 
 In the initial period many ingenious methods were discovered 
for the closure of ASD. They were atrioseptopexy, external suturing, 
Sondergrads external suture closure and inflow stasis method. 
 Another interesting method discovered by Grass was the atrial 
well technique. With the invention of cardiopulmonary bypass 
machine by John gibbon in 1953, a golden era for cardiac surgery had 
started. Open heart surgery had become possible. He first used this 
technique and closed the ASD in a young woman using a pump 
oxygenator. 
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Embroyology:   
 Formation of the atrial septum starts in the 4
th
 week of 
gestation. Two septae develop parallel to each other. The septum 
primum starts to develop as a crescentric septum at the postero 
superior aspect of the left of the atrial heart field. It grows towards the 
endocardial cushions which are separating the ventricles. The ostium 
primum is the gap between the endocardial cushion and the septum 
primum. The ostium secondum (OS) is formed when there is 
resorption of the septum primum‟s superior aspect. During this time 
the septum secondum starts to develop immediately rightward of the 
septum primum, it closes the ostium primum and circumscribes the 
fossa ovalis. The septum secondum‟s free edge acts as a flap valve for 
the fossa ovalis allowing only the right to left shunt. 
 Conditions that affect the formation of the valve or impairment 
of the valve results in persistent inter atrial communication. The 
secondum defect lies within the perimeter of the fossa ovalis and its 
morphology varies from a slit like patent foramen ovale (PFO) to a 
confluent defect involving a part or all of the fossae. ASD-OS can also 
form due to maldevelopment of the septum secondum or septum 
primum that results in inadequate closure of the ostium secondum.  
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Natural History: 
PFO is present in 60% of newborns. At one year of life it is 
present in 92-99% of babies. Secondum ASD in children accounts for 
10% of congenital heart disease and 20-40% of adult ASDs (Sabiston 
et al).  
 Spontaneous closure of ASD occurs only when the size of ASD 
is less than 4millimeters at infancy
10
. Spontaneous closure does not 
occur after three to four years of age. When the size is more than 10 
millimeters at diagnosis then the ASD does not close spontaneously. 
Adults with ASD are symptomatic mostly and they would have 
already developed pulmonary hypertension. Even when symptoms are 
absent there is reduced exercise capacity. When adult ASDs are not 
repaired the life expectancy is reduced to 40 to 50 years. The 
incidence of pulmonary hypertension increases after 30 years of age in 
those patients who have an ASD.  
 In most adult patients with RV dysfunction, right ventricular 
volume overload is the best predictor of exercise capacity
8
. The shunt 
through the defect increases with age. Hemodynamically small ASDs 
need not be closed. Subacute endocarditis may occur in ASD patients 
but the incidence as such is very low. Atrial septal endocarditis has 
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occurred in patients with ASDs and also by septal involvement of 
endocarditis by endocarditis involving the other structures of the heart.  
Associated defects: 
 ASDs can occur isolated. But, it is found many times to be 
associated with defects like ventricular septal defect (VSD), patent 
ductus arteriosis (PDA) and mitral valve prolapse (MVP). VSD was 
present in 18% of ASD patients. Left sided obstruction like mitral 
stenosis (MS) and aortic stenosis (AS) are present in 29% of patients 
with ASD. Right sided obstruction like pulmonary stenosis was 
present in 31% of ASD patients. ASD can be associated with mitral 
stenosis and dilated pulmonary artery, a condition termed 
Lutembacher‟s syndrome. This was more common in the era when 
rheumatic heart disease was common. Non rheumatic mitral stenosis 
can also be associated with ASD. Some patients with ostium primum 
ASD present with cleft anterior mitral leaflet. MR is associated with 
ASD and it is present 2.5- 10% of patients with large ASD. MVP is 
present in 20% of patients. MR in ASD patients occurs due to MVP. 
MVP is due to volume over load of right ventricle due to septal 
distortion which affects the mitral valve geometry. As an evidence of 
this, MVP and MR regress significantly after repair of the ASD. 
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 Tricuspid regurgitation (TR) is present in most of the patients 
with large ASD. This is due to annular dilatation. This condition 
reverses after repair of the ASD. Other associated anomalies with 
ASD are VSD and patent ductus arteriosis (PDA) (1%), valvular 
pulmonary stenosis (VPS) (4%), left superior venacava (LSVC) (5%), 
peripheral pulmonary artery stenosis (1%) and azygoz extension of 
IVC (1%)
1
.   
 „P‟ wave abnormalities usually accompany patients with ASD. 
P wave duration is increased. The P wave duration reduces after the 
repair of ASD in young patients implying that problem is due to 
chronic stretching of the atrial wall. Although in elderly patients and 
those who have prior paroxysmal atrial fibrillation this reversal does 
not occur. ASD is associated with syndromes like Noonan‟s syndrome 
where there is associated VPS also, Holt Oram syndrome and in 
trisomy 21 as the part of the endocardial cushion defect.  
Pathophysiology 
       During the early neonatal period pulmonary vascular resistance is 
very high and the RV and LV chamber pressures are equal, hence only 
slight shunting of blood between the two chambers. With growth of 
the neonate the pulmonary vascular resistance starts falling and the left 
ventricle starts maturing and the left atrial pressure increases and the 
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shunting, hence there is shunting of blood from left to right. Increase 
in the shunt results in volume overload and hypertrophy of the right 
ventrticle and the flow through the pulmonary valve also increases. 
Due to volume overload of the RV the interventricular septum (IVS) 
bulges into the LV. This can impede LV filling and also causes 
systolic anterior motion (SAM) of the mitral valve. This results in LV 
dysfunction. RV hypertrophy causes reduced coronary reserve. LV 
dysfunction becomes more prominent with exercise and it is more 
often a diastolic dysfunction. This dysfunction reverts to normal 6 
months after surgery.  
Pulmonary vascular disease:   
 Pulmonary hypertension (PHT) develops in 35 – 40% of 
patients with ASD by the age of forty years. Development of 
pulmonary hypertension disease is not uniformly related to the age and 
size of the shunt. PHT can develop earlier in patients with trisomy 21 
and premature infants. Histological examination of some ASD patients 
revealed intra-acinar and pre-acinar pulmonary vascular disease which 
suggests that this could have been a primary one or that the ASD 
could have been an incidental finding in patients with PHT disease.    
   In patients with ASD, due to increased pulmonary flow the 
pulmonary artery and arterioles dilate. As time progresses these 
  
 
Page 13 
 
  
vessels significantly dilate to accommodate the increased flow in the 
pulmonary vascular system. This causes reduced flow velocity and 
apparently stagnation leading to pulmonary artery thrombosis. These 
thrombi can embolise to different parts of the lung and cause multiple 
infarctions. This leads to pulmonary vascular occlusive disease.  
Clinical presentation: 
Most ASD patients are asymptomatic. Symptoms are more 
common in the later stages of life. Symptoms of ASD are 
breathlessness, recurrent respiratory tract infections, syncope and 
palpitations. Breathlessness and palpitations are more common in the 
elderly, while in children, breathlessness is present only on severe 
exertion. Rarely chylothorax was the presenting feature of the ASD. 
Some ASD patients are cyanosed as in the case of Eisenmengar‟s 
syndrome where there reversal of the shunt. Some patients without 
pulmonary vascular disease also presents with cyanosis. Cyanosis may 
also be due to preferential flow of IVC blood into the large ASD, 
baffled by the Eustachian valve. 
 
 
 
  
 
Page 14 
 
  
Physical examination: 
 Signs of RV volume overload and left to right shunt are present 
in patients with ASD. RV parasternal left, precordial bulge and shift of 
the apex to the left are also seen. Auscultatory findings are an ejection 
systolic flow murmur in the pulmonary area, an apical mid-diastolic 
murmur on inspiration due to increased flow across the tricuspid 
valve. A loud P2 component is present and a split S2 fixed throughout 
the respiratory cycle is prominent. The chest X ray shows an increased 
cardiothoracic ratio with prominent pulmonary vascular markings. 
Electrocardiography (ECG) shows RV hypertrophy, prolonged PR 
interval, RSR in V1 and incomplete right bundle branch block 
(RBBB). RV enlargement in ECG is seen in children. RBBB with 
right axis deviation is seen in ASD OS and RBBB with left axis 
deviation is seen in ostium primum ASD. Catheterisation studies are 
routinely performed for ASD patients. This study shows an oxygen 
step up at atrial level due to left to right shunt. A gradient of less than 
25 mm Hg across the pulmonary valve is noted due to the increased 
flow.  
 Transthoracic echocardiogram (TTE) is sensitive, specific and 
widely available. The morphology and characteristics of the ASD can 
be evaluated. ASD is seen as an ECHO drop out of variable size in the 
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interatrial septum. Colour Doppler can be used study the direction of 
the shunt. Bubble contrast echocardiography is standardly used to 
diagnose smaller intra-cardiac shunts. High resolution computed 
tomography (HRCT) and magnetic resonance imaging (MRI) are also 
used to diagnose ASDs when it is difficult to diagnose ASD by 
ECHO. MRI helps in visualizing PAPVC lying adjacent to the lung 
and airways.  
Clinical presentation of patients with ASD is dependent upon 
the type of defect, the magnitude of intracardiac shunt, and presence 
or absence of associated anomalies. The volume overload from 
interatrial shunting is generally well tolerated for long periods of time. 
Asymptomatic patients with small intracardiac shunt (QP:QS < 1.5:1), 
no cardiomegaly on chest X-ray, and only minimal enlargement of the 
right ventricle have little to no risk of developing symptoms or 
pulmonary vascular complications and repair is unnecessary. For 
patients with larger shunts (QP:QS > 1.5:1), onset of symptoms may be 
expected beyond the second decade of life. The magnitude of 
intracardiac shunting may increase with age as left ventricular 
compliance decreases. The most common presenting symptom is 
reduced exercise tolerance with dyspnea and fatigue resulting from 
chronic volume overload of the right ventricular. Beyond 30 years of 
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age, there is increasing risk of palpitations and arrhythmia resulting 
from atrial dilation. The onset of arrhythmia, either atrial flutter or 
fibrillation, usually causes a rapid deterioration in functional status 
because of loss of coordinated atrial contraction in the setting of right 
ventricular dysfunction. Patients who develop SVT will probably have 
persistent arrhythmia after successful ASD closure, especially if 
beyond 40 years of age. These patients should be considered for 
arrhythmia ablation during ASD repair. 
Older patients with an unrepaired hemodynamically important 
ASD may develop pulmonary vascular occlusive disease, although 
this is far less common and delayed in comparison to patients with 
VSD. Pulmonary vascular disease leads to a reversal of intracardiac 
shunting and systemic desaturation. Overall, patients with unrepaired 
ASD with QP:QS > 1.5:1 have a decreased life expectancy with an 
average life expectancy of 45 to 50 years. 
Associated Lesions  
Frequently older patients with an ASD develop tricuspid 
insufficiency and subsequent atrial arrhythmia. Other long-term 
complications of ASD such as mitral valve incompetence, pulmonary 
valve complications, and systemic arterial hypertension may be 
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observed. Because of the potential for bidirectional shunting at the 
atrial level, patients with ASD are at increased risk of paradoxic 
embolization. Emboli within the systemic venous circulation that are 
normally cleared by the lungs may cross the ASD and enter the 
systemic arterial circulation. Cryptogenic stroke (i.e., a stroke with no 
source other than a paradoxic embolus) may occur in patients with 
patent foramen ovale (PFO). 
SURGICAL INTERVENTION  
Indications  
The patients benefiting most from ASD closure are those for 
whom pulmonary hypertension will develop, but once pulmonary 
hypertension is present, surgical risk increases. This principle is the 
basis for the recommendation to close all significant ASDs. Elective 
closure of ASD is generally recommended when the Qp:Qs  is 1.5:1 or 
greater, ideally performed at age 2 to 5 years, before exercise capacity 
changes, while chest wall compliance is optimal, and before school 
age
2
. An echo diagnosis of a significant defect with right ventricular 
volume overload is common and sufficient indication to close an 
ASD. Long-term follow-up data after surgical ASD closure show 
survival equal to the normal population when repair is performed early 
  
 
Page 18 
 
  
in life, with age-related diminution in survival. Twenty-seven-year 
survival for those operated on after 40 years of age is only 40%.  
Irreversible pulmonary hypertension is the only contraindication 
to ASD closure. It is important to consider that, in a high flow state, 
with a large Qp:Qs, high pulmonary artery pressure may not represent 
fixed pulmonary hypertension. Generally, irreversible pulmonary 
hypertension is characterized by a pulmonary vascular resistance 
(PVR) 8–12 wood units/m2, with Qp:Qs <1.2:1, despite a vasodilator 
challenge. 
Moderate pulmonary hypertension with a reactive component is 
not a contraindication to ASD closure, though pulmonary 
hypertension may progress in these patients regardless of closure. 
Guidelines for inoperability are largely based on VSD data. Generally, 
the PVR must fall below 7 U/m
2
 with vasodilator therapy at cardiac 
catheterization for ASD closure risk to be less than prohibitive. 
Vasodilators used at cardiac catheterization to determine the reversible 
component of pulmonary hypertension include hyperoxia, inhaled 
nitric oxide, and isoproterenol. 
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Device versus Surgical Closure  
A majority of ASDs today are closed by a variety of catheter-
based devices, although the Amplatzer ASD occluder is the only Food 
and Drug Administration (FDA)-approved device at this time. The 
success rate and morbidity are nearly equal with the two approaches. 
Current published studies comparing device closure versus surgical 
closure with anatomically similar defects show a device success rate 
of 80% to 95.7%, compared with 95% to 100% success of surgical 
closure, though the success of device closures continues to evolve. 
Complications requiring treatment occur in 0% to 8% of device 
closures and 23% to 24% of surgical closures, and mean length of 
hospital stay is 1 day in the device group versus 3.4 days in the 
surgical group. Continual advances in the hardware and experience 
with device closures are improving the success rate of these catheter-
based approaches. 
Conflicting cost data currently fail to definitively favor device 
or surgical closure as the more cost-effective approach. The major cost 
at present for the surgically closed ASD is intensive care unit cost, 
whereas the major cost of the device closure is the device itself. Cost 
advantage may or may not favor device closure, particularly in light of 
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strategies of early extubation and accelerated postoperative 
management protocols. 
Anatomical determinants that prohibit device closure remain the 
major indications for surgical ASD closure in the current era. Defects 
unsuitable for device closure include those that have failed attempted 
device closure, common atria or those without sufficient septal rim to 
engage the device, and sinus venosus defects for which device closure 
would threaten obstruction of pulmonary veins, IVC, or SVC. 
Anterior-inferior septal deficiency can be prohibitive of device 
closure, as the device can interfere with the tricuspid valve, mitral 
valve, or coronary sinus. Individual deficient septal rims, while 
originally constituting contraindication to device closure, no longer 
are absolute contraindications but may reduce success rates. The 
largest Amplatzer septal occlusion device presently available in the 
United States is 38 mm, and defects exceeding this size would require 
surgical closure. Multiple defects can be closed with multiple devices, 
though the cost of multiple device closures may exceed the cost of 
surgery
3
. Determinants of the limitations to device closure are under 
evolution as devices and their delivery systems continue to undergo 
refinements.  
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OPERATIVE TECHNIQUE:  
Secundum ASD  
The standard surgical incision for the repair of ASD is the 
median sternotomy. A portion of the anterior pericardium is preserved 
for use as a patch. Although other materials can be used, we prefer an 
autologous pericardial patch, treated with glutaraldehyde. Bicaval 
venous cannulation, mild hypothermia, and antegrade cardioplegia are 
employed to provide a still, blood-free field through which to expose 
the interatrial septum via right atriotomy made in parallel to the 
atrioventricular groove. A careful examination of the interatrial 
septum is carried out to ensure the correct identification of the margins 
of the defect. The SVC and IVC are identified, with special attention 
to any structures that might represent partial anomalous pulmonary 
venous return to the right atrium or vena cavae. The Eustachian valve 
is carefully identified to avoid the error of baffling the IVC to the left 
atrium. The coronary sinus is identified and protected from inclusion 
in the suture line, as impaired venous effluent from the coronary 
circulation can result in precipitous cardiac edema and heart failure 
after separation from cardiopulmonary bypass. A determination is 
made to close the defect primarily where there is sufficient septum 
primum tissue, or with a patch. Care is exercised to place sutures 
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firmly into surrounding tissue but without interfering with the adjacent 
non-coronary sinus of the aorta superiorly, the tricuspid or mitral 
valves anteriorly, the coronary sinus and atrioventricular AV node 
inferoanteriorly, the IVC and right lower pulmonary vein orifice 
inferiorly and posteriorly, or the right upper pulmonary vein and SVC 
superoposteriorly 
Minimally Invasive Approaches  
A variety of alternatives to the median sternotomy have been 
described for the repair of numerous cardiac defects, most notably the 
ASD. An inframammary incision with right anterolateral thoracotomy, 
bilateral anterior thoracotomy, or median sternotomy provides 
exposure of the right atrium with a scar that is more easily concealed 
than the full median sternotomy, though these approaches may risk 
phrenic nerve palsy, lung herniation, scoliosis, and breast or chest 
muscle deformity
4. The subxiphoid “ministernotomy” or partial lower 
sternotomy can be performed safely through incisions as small as 3.5 
cm, with cannulation through the incision. Smaller incisions still, 
without any sternotomy, have been described, with video-assistance 
and femoral cannulation. Video-assist technology also permits ASD 
closure through a small right thoracotomy. Though these alternative 
incisions may confer a cosmetic advantage over the standard midline 
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incision and median sternotomy, it has been difficult to demonstrate 
objective advantages in chest wall stability, pulmonary physiology, 
pain, or length of hospital stay. Robotic-assisted closure of ASD is not 
widespread, but advances in the field of robotics promise to introduce 
newer approaches to ASD repair as well as other cardiac procedures 
through diminishing invasive incisions. 
Complications of Surgery  
Complications following the surgical closure of ASD include 
early- or late-patch dehiscence, thromboembolism, and arrhythmias 
such as heart block, sinus node dysfunction, and atrial fibrillation or 
flutter. In the rare context of ASD closure with pulmonary 
hypertension, systemic venous hypertension, right ventricular failure, 
and low cardiac output can result acutely, necessitating a return to 
cardiopulmonary bypass to fenestrate the closure. 
Though early sinus node dysfunction occurs in 9% of patients 
undergoing repair of superior sinus venosus defects by either Warden 
procedure or baffle and SVC patch, 8-year follow-up data show no 
persistent late sinus node dysfunction following these procedures. 
At examination of outcome 27 to 32 years after surgical repair 
of ASD, age at the time of repair is an independent risk factor for late 
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complications, including late cardiac failure, stroke, and atrial 
fibrillation, all of which are more frequent when the age at repair is 
older than 25 years. Independent risk factors for the development of 
atrial fibrillation with ASD, repaired or not, include age over 25 years, 
left atrial enlargement, and mitral or tricuspid regurgitation. Thirty to 
forty percent of patients over 40 who exhibit atrial fibrillation after 
ASD repair may have an embolic event within 10 years of ASD repair, 
and systemic anticoagulation is recommended in this group. 
 
Catheter-Based Treatment  
King and Mills reported the first catheter-delivered ASD 
closure in 1976, using a double umbrella device and a 23-Fr delivery 
catheter. The large-delivery catheter size precluded its use in children. 
The clamshell occlusion device, reported in 1990, could be delivered 
through an 11-Fr sheath, bringing device closures to the pediatric 
population. Device arm fracture resulted in its redesign, and a variety 
of other devices appeared and remain in use
5
. Current devices include 
the CardioSEAL (Nitenol Medical, Boston, MA), the Amplatzer 
(AGA Medical Corp., Golden Valley, MN), the Sideris buttoned 
occluder (Custom Medical devices, Amarillo, TX), the Das Angel 
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Wings device (Microventa Corp., White Bear Lake, MN),
[23]
 the 
ASDOS device (Osypka Corp., Rheinfeldon, Germany), the Helix 
septal occluder (W.L. Gore & associates, Inc., Flagstaff, AZ), and a 
transcatheter polyurethane foam patch. 
Complications of Device Closure  
The reported overall complication rate following catheter-
deployed ASD closure devices is about 8%. Included among cardiac 
complications are device malposition or dislocation, early or late 
embolization, arrhythmia, pericardial effusion, left or right atrial 
thrombus, atrial or ventricular perforation, mitral or tricuspid 
regurgitation, aortoatrial fistula, eustachian valve entrapment, and 
sudden death
6
. Mitral or tricuspid regurgitation can result from device 
entrapment within chordae, chordal rupture, or leaflet perforation by 
the device or the delivery system. Reported noncardiac complications 
include iliac vein dissection, retroperitoneal or groin hematoma, and 
leg ischemia.  
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OUTCOME  
Physiology of ASD Closure  
Subtle changes in exercise performance in ASD patients can be 
measured even in childhood
7
. An abnormal ventilatory threshold 
during submaximal exercise returns to normal by 6 months after repair 
of ASD in patients under 5 years of age, but remains subnormal for 
patients repaired older than 5 years. Most patients older than 5 years 
old at the time of repair have at least some residual RV dilation and 
abnormal septal wall motion after ASD closure, not predicted by 
preoperative shunt or ASD size. The clinical significance of this 
finding is unclear. These data may further support a strategy of ASD 
closure before school age. 
Adult  
Though the adult with ASD clearly benefits by improvement in 
exercise physiology and reduction of RV dilation after closure of 
ASD, the improvements are less pronounced with advancing age. 
There is a clear survival advantage and a reduction in the incidence of 
cardiovascular events for ASD closure to the age of 40, compared to 
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medical management. Some controversy remains as to the best 
treatment strategy in the older adult population
11
. 
Regardless of the presence of symptoms, RV and RA 
enlargement in adults decreases after surgical or device closure of 
ASD, though right atrial enlargement persists proportional to the age 
at repair. Though younger adults demonstrate an improved VO2 max 
within months of ASD closure, patients older than 40 years who 
undergo repair may take several years to show exercise improvement. 
The incidence of atrial fibrillation is similar for the patient older than 
40 years, whether surgically or medically treated
12
. Though its onset is 
sooner after surgical closure of ASD, the arrhythmia has a higher 
relation to long-term mortality in the medically treated group. The 
significant incidence of sustained postoperative atrial fibrillation 
suggests that a Maze procedure concurrent with ASD closure may be 
advisable for the patient older than 40.  
Prior to ASD closure, >60% of patients older than 40 are 
NYHA class III to IV, whereas after ASD closure, >80% are NYHA 
class I to II. Patients older than 60 show functional class improvement, 
immediate and late reduction in pulmonary artery pressure, and 
improved 5- and 10-year survival after ASD closure, by comparison to 
medical management. These data support a strategy of ASD closure 
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regardless of age for the symptomatic patient, though some 
controversy remains over the closure of the asymptomatic ASD after 
age 40, as functional class deterioration and arrhythmia has been 
observed in this group after ASD closure.  
In a study done by Kambet et al on cross sectional ECHO on 
mitral valve prolapse associated with ostium secondum ASD, a 
preoperative and postoperative comparative study on 71 patients, the 
incidence of MVP was 53.2%. Anterior MVP was found in 36% 
patients. Posterior MVP was found in 3 patients and 2 patients had 
both.  Anterior MVP decreased in incidence from 28 patients to 17 
following ASD closure, whereas posterior MVP remained unchanged 
even after surgery. 
Speechly et al. has done a study on long term surgical outcome 
and the problem of  late MR in secondum ASD on 52 patients with a 
mean age of 33 years with ASD. 52 patients underwent direct suture 
closure and 3 patients underwent pericardial patch closure. In this 
series surgical mortality was zero. Late postoperative morbidity 
happened in 2 patients, one of them required mitral and tricuspid wall 
replacement and the other patient developed cardiac failure. Both 
these patients were above 60 years of age. 2 patients developed sinus 
node dysfunction and required permanent pacing. Atrial fibrillation 
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(AF) persisted even after surgery in 6 patients. New AF developed in 
two elderly patients. MVP was present pre operatively in 9 (16%) 
elderly patients (p < 0.001). These patients had high pulmonary artery 
pressure (p<0.001). MVP persisted in these 9 patients postoperatively. 
MVP and MR developed newly in 5 patients postoperatively of which 
one patient needed MVR and TVR. 
Takahashi H et al. in a study on MVP in patients with 
postoperative ASD involving 90 patients reported that the preoperative 
incidence of MVP in their study was 78% and postoperative incidence 
was 56%. Improvement of MVP was noted only in 24% of patients. 
No case of MVP newly developed after the surgery. In those patients 
with persistent MVP after surgery was associated with a large QP/QS, 
high pulmonary artery pressure and right ventricular dilatation. In 
those patients with MVP after surgery the resultant MR was not 
significant.   
 In a study done by Gatoulis M A et al. on atrial arrhythmias 
after ASD closure in adults on 213 patients of which 82 were men and 
131 were women. The preoperative incidence of AF was 19% (40 
patients). AF was not present in the age group between 37±13 years 
(p< 0.01) and the pulmonary arterial pressure (PAP) was 19.7+8.2 mm 
Hg. AF was prevalent in the age group of 59±11 years. The PAP in 
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this group of patients was 29±9.7 mmHg. There was no perioperative 
deaths reported in this study. After a mean follow up of 3.8±2.5 years, 
24 out of 40 patients (60%) continued to have AF. Mean age of these 
patients was greater than that of 16 patients whose rhythm converted 
to sinus rhythm (p<0.02)
19
. Late events (one month after surgery) 
included stroke in 6 patients and death from noncardiac cause in 2 
patients. The risk of AF in adults with ASD was related age at the time 
of surgery and the pulmonary arterial pressure.  
 Horer J et al. did a study on surgical closure of ASD in 
patients older than 30 years and evaluated the risk factors for late 
death from arrhythmias and heart failure. The long term follow up of 
281 adult patients who underwent ASD closure was reviewed. The 
mean age at surgery was 43.8 ±10 years (30-76 years). There were 2 
early deaths. Death from arrhythmia or heart failure was present in 9 
patients at a mean time of 8.5± 6.6 years after operation. Patients more 
than 43 years exhibited a high PAP. Preoperative pulmonary artery 
systolic pressure (PASP) more than 36 mmHg and mean PAP more 
than 21 mm Hg were predictive of late death due to arrhythmia or 
heart failure.   
 Jose M et al in their study on surgical closure of ASD before or 
after the age of 25 years compared the natural history of operated and 
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unoperated patients. In this study the age group of patients were 
between 31 ± 19 years. 70% of the patients were of female sex, age at 
surgery was 31± 20. The diastolic RV size was 27± 7 mm and PAP 
was 34 ± 14 mm Hg. Degree of mitral insufficiency was 0.7± 0.8. 
Degree of tricuspid insufficiency was 1.2 ± 0.8. The LV diameter was 
42 ± 11 mm. The incidence of AF was 17% and 9% (25 of 280 
patients) had tricuspid regurgitation (TR). 2 % of the patients who had 
surgery before the age of 25 years presented with serious TR, whereas 
18% of  patients who were operated after the age of  25 years had TR. 
The left atrial size was more than 40 mm in 54% of patients and more 
than 50 mm in 20% of patients. 
 Attie F et al. did a study on 521 patients on surgical treatment 
of secundum ASD in patients more than 40 years old, a randomized 
control trial study. It was a prospective study measuring the long term 
clinical outcome. Of these 521 patients 232 underwent surgery and 
241 underwent medical management. The primary and secondary end 
points were 1) Major cardiovascular events (functional class 
detoriation or heart failure, pulmonary embolism, major arrhythmic 
event, cerebro vascular event, recurrent pulmonary infection and 
death) 2) Overall mortality. Risk of mortality was high in the medical 
management group. Anatomic closure of ASDs should always be 
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attempted as a first treatment of ASD in adults older than 40 years of 
age with PASP less than 70mm Hg and QP:QS ≥ 1.7. The operation 
must be done earlier when symptoms of hemodynamic effects seem to 
be minimal. 
 Kodo T et al. in their study titled surgery of ASD in patients 
aged over 40 years: comparative study of direct suture closure and 
pericardial patch closure on 39 patients, evaluated the postoperative 
complications. Patients who underwent patch closure (13 patients) had 
a larger defect. In the group of patients who underwent direct closure 
(27 patients), there was one patient with pulmonary stenosis. In the 
other group 2 patients had mitral valve disease and 6 patients had 
pulmonary hypertension (PHT). In the direct closure group, incidence 
of heart failure was 29% and arrhythmia was 47% whereas in the other 
group incidence of heart failure was 61% and arrhythmia was 69%. In 
33% of patients aged over 40 years with ASD heart failure developed 
after ASD closure. 
 In a study that evaluated left ventricular adaptation after ASD 
closure by increased concentration of  N-terminal pro-brain natriuretic 
peptide (BNP) and cardiac MRI in adult patients showed that NT-pro 
BNP increased after interventional closure of the ASD. This increase 
was associated with increase left ventricular dimension as assessed by 
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MRI. Later after surgery NT-pro BNP returned to baseline
20
. This 
suggested that the presence of transient hemodynamic stress on left 
ventricle leading to acute heart failure that explains the late 
improvement that occurs in exercise capacity after ASD closure.  
 In a study done by Beyer J at al. on 716 patients evaluating 
acute left heart failure following repair of ASD and its treatment by 
ASD. 15 of these patients developed acute left heart failure requiring 
partial reopening. Some patients had severe PHT which led to right 
ventricular hypertrophy (RVH). There was marked difference in 
stroke work between the right and left ventricle. High incidence of left 
heart failure as a cause of death after repair of an ASD indicates the 
importance of the complications. 
 In a study of ASD over 60 years of age and older evaluated the 
operative results and long term postoperative follow up. 56 patients 
were divided into 3 groups according to the PASP. In these groups 
there was no significant difference in QP/QS, RA, LA pressures, right 
and left ventricular end diastolic pressure but pulmonary vascular 
resistance index was more significant when the PASP was more than 
60 mm Hg. Operative mortality was 6%. All of these patients 
underwent appropriate additional procedures. The operative mortality 
was unrelated to the preoperative functional class, PAP are pulmonary 
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vascular resistance (PVR). The patients improved symptomatically 
regardless of the functional class, PAP or PVR. There was significant 
longevity at 5 and 10 years after surgery when compared to the 
medical treatment.  
 Felix et al. studied the incidence of atrial fibrillation and atrial 
flutter in adults with ASD before and after surgery. The study was 
done on 211 adult patients with ASD. Holter monitoring was done 
preoperatively and early and late postoperatively. These patients were 
divided into 3 groups according to their age groups. Atrial flutter was 
significant in the age group of 54±12 years whereas atrial fibrillation 
was significant in the age group of 59± 8 years. Atrial flutter 
converted to sinus rhythm in 10 out of 18 patients postoperatively and 
atrial fibrillation converted into sinus rhythm in 21 out of 28 patients. 
The surgical repair of ASD to treat supraventricular tacchyarrhythmias 
(SVT) is warranted in adults but when atrial fibrillation is present, 
sometimes it may have to be combined with Maze operation. 
Shah et al
13
. published a prospective study on the natural 
history of OS-ASD in adults after medical and surgical treatment. In 
the nonsurgical group 13 patients (43%) had TR, mild TR was present 
in 7 patients and moderate TR in 6 patients. Average TR velocity was 
3.1 m/sec and peak gradient was 39.04 mm Hg. In the surgical group 8 
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patients (17%) had mild TR with TR velocity was 2.7 m/sec and the 
peak gradient was 29.5mm Hg. In the medically managed group atrial 
fibrillation was present in 45% of patients above the age of forty 
years, which was comparable to 51% of patients as reported by 
Murpy et al. in the same age group.  
Sutton et al
18
. reported an incidence of atrial fibrillation to be 
58% in his series. The percentage of atrial fibrillation in surgical group 
was 40% in the age group of 40 years and 58% for patients in the age 
group of 60 years. All systemic embolic episodes occurred in patients 
who had atrial fibrillation and their incidence was equal in both 
groups. Warfarin was the treatment of choice to prevent embolism in 
patients with atrial fibrillation.  45% of the medically managed group 
and 50% of the surgically treated patients was receiving diuretics to 
treat congestive cardiac failure. All these patients had atrial 
fibrillation.  
In the above mentioned study the authors reported that the LV 
dysfunction could not be detected by ECHO. RV was dilated in both 
the operated and unoperated group of patients but their function was 
good in both the groups. RV thickness was essentially the same in 
both groups. Cardiac failure was due to TR and atrial fibrillation. The 
frequency of raised venous pressure was not influenced by surgical 
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treatment though TR was detected more significantly by Doppler 
ECHO in the medical group.  
M Vogel et al
14
. studied the incidence of secondary PHT in 
adults with ASD and sinus venosus defect. This study involved 31 
patients with SVC type ASD and 138 patients with ASD-OS. In the 
SVC defect group there was significantly higher systolic, diastolic and 
mean PAP and PVRI than the ASD-OS group. PHT was present when 
mean PAP was more than 30 mmHg. Incidence of PHT was 26 % in 
SVC ASD and 9% in ASD-OS group. Raised PVRI (Rp/Rs > 0.3) was 
present in 60% of SVC group and 4% with ASD-OS group. Raised 
PAP and PVRI was more apparent in the age group of more than 40 
years than the 18-40 years group and there was no progression of 
pulmonary vascular disease (PVD) in patients more than 60 years
21
. 
Significant correlation was present between age and New York heart 
association (NYHA) class in both the groups however the correlation 
was more significant for the SVC group. 2 patients in each group were 
listed for heart lung transplant. 1 patient with SVC ASD died. He was 
58 years old. In this patient the PAP was 68 mm and Rp/Rs was 0.4. 
He had a left to right shunt with a QP/QS of 1.8: 1. The left to right 
shunt increased with oxygen and so surgery was done. Postoperatively 
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patient developed PHT crisis six hours after surgery and the patient 
died  
 C A Boucher et al
15
. did a retrospective analysis of 235 adults 
with ASD-OS and evaluated the incidence of MR, its management and 
morphologic basis. In this study 4% (10) of patients had significant 
MR. 3 of them required MVR along with the ASD surgery. 4 patients 
had ASD closure alone, in which one of them required MVR after 5 
years. 3 patients did not undergo surgery due to coexisting comorbid 
illness. 6 patients had their mitral valve studied pathologically and it 
revealed that 3 had myxomatous disease and the other 3 where of 
rheumatic origin. Their data shows that the association between MR 
and ASD was not significant. The morphology of the mitral valve 
were mainly chordal and leaflet thickening, fibrosis and deformity and 
not thinning and ballooning as in MVP.  
 All the patients in the above mentioned study presented with 
symptoms and were on digoxin and diuretics.one patient had 
congestive cardiac failure (CCF). 7 had atrial fibrillation and left atrial 
enlargement in ECG. 3 patients had LVH on ECG. All of them had 
generalised cardiomegaly in their chest X-ray right ventricle and 
pulmonary artery was prominent. 8 patients had radiological evidence 
of left atrial enlargement. In 3 patients who underwent MVR 2 
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patients are in NYHA class I after 2 and 6 years. Third patient died of 
severe right and left heart failure. In the 4 patients with isolated ASD 
closure postoperative LA pressure was elevated and all of them 
continued to demonstrate significant clinical MR and one of them 
subsequently required MVR after 5 years but he died one year after 
the surgery. The fifth patient developed grade II symptoms and left 
atrial enlargement over 5 years. Sixth and seventh patients were in 
grade I after 5 years. Incidence of MR was uncommon in young 
patients with ASD and more common in elderly patients. The residual 
MR is significant after ASD closure. Pulmonary venous and left atrial 
pressure increased and caused symptoms in 2 patients.  
 MVR at the time of ASD repair should be waited against the 
long term risk of anticoagulation. The decision to replace the valve 
should be done after inspecting the valve elements, partially occluding 
the ascending aorta to increase the afterload and by volume 
overloading. These maneuvers unmasks significant MR. When MR is 
severe MVR is done in the same setting. When MR is less significant 
MVR is delayed but it may be required subsequently. Hence surgery 
in patients with ASD and MR were delayed until significant symptoms 
developed, so that at the same setting both defects are repaired.    
  
 
Page 39 
 
  
 MJ Davis et al
16
. in the study of 16 adult hearts with ASD 
studied the morphology of the mitral valve. 15 of these hearts showed 
thickening of medial half of the anterior cusps and fusion of chordae, 
fibrosis and neovascularization and myxomatous degeneration. The 
function abnormality in mitral valve was due the changes caused by 
increased flow and altered LV geometry. 
 TL Schreiber et al
17
. in their study on effect of atrial septa 
defect repair on LV geometry and degree of MVP in 14 patients 
reported that cross sectional ECHO showed MVP in 7 patients (50%) 
preoperatively. The degree of prolapse was studied by measuring the 
net algebraic area subtended by the area of apposed surface of the 
leaflet in systole with respect to mitral ring. In patients with MVP the 
area was 0.3 ± 3.1 Units and in patient with no MVP the area was 12.5 
± 3.1 Units. Post-operative prolapse was reduced or abolished in 6 of 7 
patients (86%) and the mitral valve apposing surface area was 14.7 ± 
4.4 Units after ASD closure. RV internal dimension index (RVidi) 
reduced from a preoperative value of 2.69 ± 0.16 cm /m
2
 to 2.19 ± 
0.17 cm /m
2
 post operatively. Mean LV internal dimension (LVidi) 
reduced from 3.16 ± 0.21 cm /m
2
 preoperatively to 3.64 ± 0.19 cm / 
m
2
 but it was not significant. In 1 patient RVidi remained in the upper 
limit even after surgery because of the chronic changes due to left to 
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right shunting. No significant changes noted in the LA dimension. 
Septa motion normalized in 86% of the patients.  
 MG St John Sutton et al
18
. did a study in 53 patients with ASD 
assessing the left ventricular function by complete analysis of the M-
mode ECHO. LV function was assessed by computer assessed 
analysis of LV Echo and cardiac catheterization. There were two 
groups of patients one above 60 years and other was below 60 years. 
Cavity size and septal motion were abnormal in 86% but cardiac index 
left ventricular end diastolic pressure, fractional shortening, rapid 
filling and LV filling were grossly normal. They concluded that in 
patients with ASD the LV function is normal irrespective of increased 
age RV failure and PHT. The abnormal septal motion is compensated 
by enhanced septal and posterior wall percentage thickening.  
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MATERIALS AND METHODS 
 
Study design 
Retrospective study 
Methodology 
Subject Selection: 100 patients 
Inclusion Criteria: All patients with Atrial septal defect of 
ostium secundum type between 12 to 60 years of age with a 
significant left to right shunt with Qp /Qs of 1.5: 1 or greater  
and patients with ASD OS with symptoms 
Exclusion Criteria: ASD Ostium Secundum (OS) type 
associated with complex congenital malformations, ASD OS 
with severe Mitral or Tricuspid regurgitation, angiographically 
confirmed acquired coronary artery disease, ASD associated 
with Partially Anomalous Pulmonary Venous Connections 
(PAPVC) 
Analysis Plan: Comparison of outcomes of both the surgical 
techniques- duration of the surgery, cardio pulmonary by pass 
time , changes in chamber geometry, aortic cross clamp time, 
need for blood products, thromboembolism, infections, other 
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complications, duration of hospital stay and relief from 
symptoms 
Screening Procedures / Visits: Postoperative 
Transthoracic echocardiography 
Follow up Procedures / Visits: Transthoracic 
echocardiography 
Assessments of Parameters:  
ECG- Reduction in QRS duration 
ECHO- Left ventricle internal diastolic dimension (LVID), 
Right ventrical internal diastolic dimension (RVID), Mitral 
regurgitation (MR), shunt fraction, residual shunt. In this study 
transthoracic ECHO was done in all patients preoperatively, 
postoperatively and on follow up. It was a comprehensive study 
that included M mode, two dimensional ECHO, continuous 
wave, pulsed wave and colour Doppler. In the apical four 
chamber view, the transverse diameter measured was taken as 
the right ventricle size. The tricuspid regurgitant jet velocity 
was used to calculate pulmonary artery pressure. The shunt ratio 
was measured by taking into account the velocity time integral 
(VTI) and the cross sectional area at the corresponding sites in 
the left ventricular outflow tract and the pulmonary artery. MVP 
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was diagnosed when there was a sudden mid to late systolic 
posterior displacement of a part of the mitral valve to atleast 
2mm below the line that joins the point of closure of the mitral 
valve in systole to the point of opening of the mitral valve in 
diastole, with leaflet displacement superiorly, confirmed by 
cross sectional ECHO. MVP was also diagnosed when there 
was pan systolic prolapse with displacement 3mm below the 
line joining the closure and opening of the mitral valve, with the 
peak in the mid systole confirmed by bulging of the mitral 
annulus during systole on ECHO.   
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ASD OSTIUM SECUNDUM TYPE PERICARDIAL 
PATCH CLOSURE 
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DIRECT SUTURE CLOSURE OF ASD 
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RESULTS 
Clinical data 
In the study of 100 patients, 54 patients presented with 
symptoms while the remaining had no symptoms. Patients presented 
with symptoms like breathlessness on exertion, palpitations, fainting 
attacks, tiredness, recurrent respiratory tract infections and atypical 
chest pain. The mean age of patients in the pericardial patch closure 
group was 38 ± 6 years and in that of the direct closure group mean 
age was 41 ± 7 years (Table 1).In the first group 62% were females 
and in the second group 50% were females. 27 % of patients in the 
first group and 30% in the second group were in NYHA class II-III 
respectively.  Atrial fibrillation was present in 24 of the 100 patients at 
the time of diagnosis. 65% of the patients were females with the 
median age of 26 years and 35% were males with the median age of 
33 years. 
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Comparison between the two study groups 
Table 1 
Variables Pericardial patch 
closure group 
Direct suture closure 
group 
Age (years) 38±6 41±7 
Female 31 28 
Male 19 22 
NYHA class II & III 27% 30% 
ASD average size 26±8 mm 24±7 mm 
Total cross clamp time 16±3 mins 8±3 mins 
Cardiopulmonary bypass 
time 
35±2 mins 25±3 mins 
Residual shunt None None 
Duration of hospital stay 6±2 days 6±3 days 
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Graph 2 
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Echocardiographic (ECHO) data: 
 Average size of the ASD was 26±8mm, 24±7mm in the 
pericardial patch closure and direct suture closure group respectively. 
Mitral valve prolapse (MVP) was noted in 16 patients (30%) in the 
pericardial patch closure group (Table 2) and 12 patients (24%) in the 
direct suture closure group (Table 3). In the patients with MVP the 
pulmonary artery mean pressures were higher and these patients were 
older, most of them being above the age of forty years. Mitral 
regurgitation (MR) was present in 9 patients in the pericardial patch 
closure group, 7 of them had mild MR and 2 had moderate MR. In the 
direct suture closure group 11 patients had mild MR. None of the 
patients in both groups had a severe MR. 34 patients in the pericardial 
patch closure group and 38% in the direct suture closure had no MVP 
and their mean age was 25 years. We did not note any significant 
correlation between the prolapse and the shunt size of the ASD. All 
patients underwent prospective follow up ECHO at a mean period of 
four months from the time of surgery. 4 patients in the pericardial 
patch closure group and 3 patients in the direct suture closure group 
developed MR in the follow up period. All these patients were elderly 
patients with the mean age of 49±6 years.  
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Pericardial patch closure- Preoperative ECHO findings 
Table 2 
 
 
 
 
 
 
Direct closure group- Preoperative ECHO findings 
Table 3 
 
 
 
 
 
 
MR-Mitral regurgitation, MVP-Mitral valve prolapse, TR-Tricuspid regurgitation,                
PHT-Pulmonary hypertension 
 
 
ECHO findings No. of Patients Percentage 
Mild MR 7 14% 
Moderate MR 2 4% 
MVP 16 30% 
Mild TR 11 22% 
Moderate TR 12 24% 
ECHO 
findings 
No. of Patients Percentage 
Mild MR 8 16% 
Moderate MR 3 6% 
MVP 12 24% 
Mild TR 10 20% 
Moderate TR 6 12% 
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Echocardiographic parameters 
Table 4 
Pericardial patch closure group Direct suture closure group 
Parameters Preoperative Postoperative Preoperative Postoperative 
RV size (mm) 45±8 37±5 43±6 39±3 
LVID (mm) 31±3 36±2 34±3 37±4 
LA (cm) 2.9±0.5 2.7±0.3 2.5±0.5 2.3±0.6 
MVASI(U/m
2
) 8.0±3.3 18.3±3 11±3.6 20±5 
PAP 32±8 34±6 29±6 25±9 
 
RV- Right ventricle at end diastole, LVID-Left ventricular internal dimension at 
end diastole, LA-Left atrium, MVASI- Area subtended by the opposed mitral 
valve in systole in the long axis, cross sectional ECHO with respect to the mitral 
ring  
 
Surgical data: 
 In this study 50 patients underwent pericardial patch closure and 
another 50 patients underwent direct suture closure for ASD. We 
observed that in those patients who underwent pericardial patch 
closure the defect size was not significantly larger than in those who 
had direct repair of their defects.  There was no mortality in both the 
groups. Surgical morbidity was present in 2 patients in the pericardial 
patch closure group in the form of bradyarrythmia but they 
asymptomatic and they were treated with orciprenaline. In the follow 
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up period after 2 months the drug was slowly withdrawn and 
bradyarrhythmia did not recur in these patients. None of them needed 
a permanent pace maker implantation. Atrial fibrillation was present 
postoperatively in all the patients in both groups who had developed it 
preoperatively (Table 5). 2 patients in the pericardial patch closure 
group and 1 patient in the direct suture closure group developed new 
atrial fibrillation the follow up. 3 patients in the pericardial patch 
closure group and 4 patients in the direct suture closure group had 
transient tachyarrhythmia their mean ages were 53±5. In the 
pericardial patch closure group 1 patient aged 60 years developed 
cardiac failure and required treatment with diuretics. 2 patients in the 
direct suture closure group and 1 patient in the pericardial patch 
closure group developed acute pericarditis in the postoperative period 
and needed treatment with aspirin and steroids. 46% in the pericardial 
patch closure group and 32% in the direct closure group had tricuspid 
regurgitation. The mean pulmonary artery pressure in the first group 
was 32±8 mm Hg preoperatively and in the postoperative follow up 
period it was 34±6 mm Hg .In the direct closure group the mean 
pulmonary artery pressure was 29±6 mm Hg preoperatively and 
reduced to 25±9 mm Hg in the postoperative follow up period (Table 
4). Two patients in the PPC group and one patient in the DC group 
developed new atrial fibrillation. Four patients in the PPC group and 
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five patients in the DC group with preoperative atrial fibrillation 
reverted to sinus rhythm. The right ventricular size in the PPC group 
reduced from 45±8mm in the preop period to 37±5mm in the postop 
follow up period. In the DC group it reduced from 43±6mm before 
surgery to 39±3mm in the follow up period after surgery. Mitral valve 
apposition area in systole (MVAS) improved from 8±3.3 to 18.3±3 in 
the post op follow up in the PPC group. In the DC group the MVAS 
improved from 11± 3.6 to 20±5 in the post op follow up. 
 
 
Preoperative atrial flutter of fibrillation 
Table 5 
Variables Pericardial patch 
closure group 
Direct suture 
closure group 
Number of patients 14 10 
Qp:Qs 2.3±4 1.9±7 
PAP(mm Hg) 31±8 30±6 
 
Qp:Qs- Pulmonary to systemic flow ratio, PAP-Pulmonary artery pressure 
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Electrocardiogram and chest X-ray findings 
Table 6 
 
Cardiac events and clinical outcome after surgery 
Table 7 
Event Pericardial patch 
closure group 
Direct suture 
closure group 
Stroke 4% 2% 
Cardiac failure 16% 10% 
New onset AF 4% 2% 
Acute pericarditis 2% 4% 
 
 
 
 
 Pericardial patch closure 
group 
Direct suture closure 
 group 
Variables Pre 
operative 
Post 
operative 
Pre 
operative 
Post 
operative 
Axis 68±30 54±20 70±20 57±30 
 
PR interval 
 (m sec.) 
184±6 152±5 179±8 140±3 
 
QRS 
duration  
(m sec.) 
123±2 107±2 128±3 111±5 
R wave in  
lead V1 
2.4±2 2.2±3 2.6±5 2.3±3 
 
CT ratio in  
chest X-
ray (%) 
46±3 41±5 49±3 42±7 
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DISCUSSION 
 
              Kambet et al in their study on incidence of MVP associated 
with atrial septal defect mentioned that the incidence of MVP was 
53.2% whereas in our study the incidence of MVP was 54 %. 30 % of 
patients in the PPC group had MVP and 24% in the DC group had 
MVP. Postoperatively in the follow up ECHO the MVP reduced to 
24% in the PPC group and to 13% in the DC group. 
            Comparing our results with the study done by Speechly et al, 
surgical mortality in both study were zero. Late postoperative 
morbidity was present in 7 patients in the PPC group and 6 patients in 
the DC group in the form of atrial fibrillation, failure and acute 
pericarditis whereas in the Speechly‟s study group one patient 
required mitral valve replacement and tricuspid valve replacement and 
the other one had developed cardiac failure, two patients had 
developed sinus node dysfunction, new AF developed in two elderly 
patients. In our study, 54% of patients who had MVP  also had high 
pulmonary artery pressures. MVP improved after surgery in 10 of 
patients in the PPC group and 12% of patients in the DC group. While 
in Speechly‟s study nine preoperative patients had high PAP and MVP 
persisted in all of them post operatively and new mitral regurgitation 
  
 
Page 56 
 
  
and MVP developed in five patients. In the PPC group four patients 
and three patients in the DC group had developed new mitral 
regurgitation. These results were also comparable to the study done by 
Tahahashi H et al. In his study improvement in MVP was noted in 
24% of patients.  
              The preoperative incidence of atrial fibrillation in the PPC 
group was 28% and in the DC group was 20%. Atrial fibrillation was 
prevalent in the age group of 53±9 (PAP 31±8mmhg) in the PPC 
group and 50±7 (PAP30±6mmhg) in the DC group. On comparing 
these results with the study by Gaoulis MA et al the incidence of 
Atrial fibrillation was 19% and it was prevalent in the age group of 
59±11(PAP 29±9.7).In our patients 8% in the PPC group and 10% in 
the DC group AF reverted to sinus rhythm post operatively. 82% of 
the patients continued to have atrial fibrillation after surgery. In the 
Gaoulis study 60% continued to have atrial fibrillation after a follow 
up of 3.8±2.5 years. Three patients in the PPC group two patients in 
the DC group developed stroke in the postoperative period. 
   In our study patients who underwent pericardial patch closure 
had a bigger defect. 14% and 10% of patients in the PPC and DC 
group respectively had pulmonary hypertension. Kodo et al in their 
study noted that one patient had pulmonary stenosis in the DC group 
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and six patients in the PPC group had PHT. In the PPC group 
incidence of heart failure was 16% and 10% in the DC group and 
incidence of arrhythmia was 34% in PPC and 20% in the DC group 
while in Kodo‟s study incidence of cardiac failure and arrhythmia was 
61% and 69% in the PPC group and DC group respectively. 
 The incidence of tricuspid regurgitation in the PPC group was 
46% (23 patients), mild TR was present in 11 patients and moderate 
TR was present in 12 patients. The incidence of TR in the DC group 
was 32% (16 patients) 10 had mild TR and 6 had moderate TR. These 
results were comparable to that of the study done by Shah et al. 
Pulmonary artery pressure in the PPC group was 32±8mmhg and in 
the DC group was 29±6 in the preoperative period and on follow up it 
was 34±6 and 25±9 in the PPC group and DC group respectively. The 
incidence of heart failure was 16% in the PPC group and 10% in the 
DC group. Cardiac failure was a result of arrhythmias and TR. The 
frequency of raised PAP was not influenced by the different modes of 
treatment. Incidence of PHT was 14% in the PPC group and 10% in 
the DC group. Postoperatively 9 of the 16 patients in the PPC group 
and 10 of the 12 patients in the DC group experienced a reduction in 
the MVAS and degree of prolapse. MVAS in the PPC group was 
8±3.3 and improved to 18.3±3 and in the DC group it improved from 
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11±3.6 to 20±5 post operatively. Right ventricular size in the PPC 
group reduced from 45±8mm in the pre-op period to 37±5mm post op 
and in the DC group it reduced from a mean of 43±6mm to 
39±3mm.LVID reduced from 31±3mm pre-op to 36±2 and from 34±3 
to 37±4 in the PPC group and DC group respectively. Left atrial size 
reduced from 2.9±0.5 pre op to 2.9±0.3 and 2.5±0.5 to 2.3±0.6 in the 
PPC and DC group respectively.  
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SUMMARY 
This is a retrospective study of two groups of patients who 
underwent pericardial patch closure and direct suture closure for ASD. 
The average size of the ASDs in the pericardial patch closure (PPC) 
group was larger (26±8 mm). MVP was present in 30% and 24% in 
the PPC group and direct closure (DC) group respectively. In the 
postoperative follow up period the MVP reduced in 9 patients in PPC 
group and ten patients in the DC group. MR was present in 18% and 
22% of patients in PPC group and the DC group respectively.              
4 patients in the PPC and 3 DC group developed postoperative new 
mitral regurgitation. Preoperative AF was present in 28% and 20% of 
PPC and DC groups respectively. Of these 8% and 10% of patients 
reverted to sinus rhythm postoperatively in both groups respectively. 
The total cross clamp time and cardiopulmonary bypass time was 
longer in the PPC group. None of the patients in both groups had 
residual shunt in the postoperative ECHO. There was no difference in 
the duration of hospital stay between the two groups.  
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CONCLUSION 
 
           Cardiac surgeons vary in their frequency with which they select 
the pericardial patch technique or direct suture closure. A patch can be 
used when the defect is significantly larger or when the tissues are 
friable and there appears to be no significant difference in the results, 
early and late thromboembolic complications. When circumstances are 
ideal the ease and simplicity of direct closure supports its use in many 
patients. 
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